139 related articles for article (PubMed ID: 9490342)
1. [Prophylactic use of Neoton in cardiac failure in patients with myocardial infarction].
Perepech NB; Nedoshivin AO; Kutuzova A'E
Klin Med (Mosk); 1997; 75(10):52-4. PubMed ID: 9490342
[TBL] [Abstract][Full Text] [Related]
2. [Neoton and thrombolytic therapy of myocardial infarction].
Perepech NB; Nedoshivin AO; Nesterova IV
Ter Arkh; 2001; 73(9):50-5. PubMed ID: 11642083
[TBL] [Abstract][Full Text] [Related]
3. [Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction].
Perepech NB; Nedoshivin AO; Kutuzova AE
Klin Med (Mosk); 1993 Jan; 71(1):19-22. PubMed ID: 8046897
[TBL] [Abstract][Full Text] [Related]
4. [Neoton (exogenic phosphocreatinine) in combined therapy of chronic cardiac failure].
Nedoshivin AO; Perepech NB
Klin Med (Mosk); 1996; 74(9):45-8. PubMed ID: 9121090
[TBL] [Abstract][Full Text] [Related]
5. [Initial experience with using phosphocreatine in patients in the early (up to 6 hours) period of myocardial infarction].
Samarenko MB; Afonskaia NI; Dvoskina IS; Ruda MIa
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):75-81. PubMed ID: 3426824
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic significance of typical immune reactions in myocardial infarction].
Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic possibilities of using phosphocreatine in complicated myocardial infarct].
Golikov AP; Riabinin VA; Pavlov VA; Avilova OA; Saks VA
Ter Arkh; 1987; 59(5):50-3. PubMed ID: 3616943
[TBL] [Abstract][Full Text] [Related]
8. [Neoton in the treatment of myocardial infarct and unstable stenocardia].
Golikov AP; Riabinin VA
Kardiologiia; 1993; 33(7):15-7, 3-4. PubMed ID: 8309174
[TBL] [Abstract][Full Text] [Related]
9. [The role of intracardiac hemodynamic parameters in prognosis of cardiac failure in myocardial infarction patients].
Tarasov NI; Sizova IN; Malakhovich EV; Sergeev IuA; Barbarash OL
Klin Med (Mosk); 2001; 79(7):32-5. PubMed ID: 11523345
[TBL] [Abstract][Full Text] [Related]
10. [Systemic thrombolytic therapy in acute myocardial infarct: its effect on left ventricular function, body oxygen consumption and disease prognosis].
Perepech NB; Nedoshivin AO; Kutuzova AE; Nesterova IV; Mikhaĭlova IE
Ter Arkh; 1993; 65(8):7-12. PubMed ID: 8211809
[TBL] [Abstract][Full Text] [Related]
11. Reduction of ventricular arrhythmias by phosphocreatine (Neoton) in patients with acute myocardial infarction.
Ruda MYa ; Samarenko MB; Afonskaya NI; Saks VA
Am Heart J; 1988 Aug; 116(2 Pt 1):393-7. PubMed ID: 2456682
[TBL] [Abstract][Full Text] [Related]
12. [The effect of creatine phosphate (Neoton) in acute myocardial infarct (a prospective multicenter pilot study].
Stejfa M; Zeman K; Groch L; Marek J; Komárek J; Janota T; Vávra F; Kölbel F; Charvát I; Weinbergová O
Vnitr Lek; 1993 Feb; 39(2):136-42. PubMed ID: 8506660
[TBL] [Abstract][Full Text] [Related]
13. Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.
Abildstrom SZ; Ottesen MM; Rask-Madsen C; Andersen PK; Rosthøj S; Torp-Pedersen C; Køber L
Int J Cardiol; 2005 Sep; 104(2):184-9. PubMed ID: 16168812
[TBL] [Abstract][Full Text] [Related]
14. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
[TBL] [Abstract][Full Text] [Related]
15. [MRT assessment of metabolic and thrombolytic therapy effects on postinfarction left ventricular remodeling].
Tarasov NI; Kokov AN; Barbarash LS
Ter Arkh; 2006; 78(9):38-43. PubMed ID: 17076223
[TBL] [Abstract][Full Text] [Related]
16. Adrenomedullin administration immediately after myocardial infarction ameliorates progression of heart failure in rats.
Nakamura R; Kato J; Kitamura K; Onitsuka H; Imamura T; Cao Y; Marutsuka K; Asada Y; Kangawa K; Eto T
Circulation; 2004 Jul; 110(4):426-31. PubMed ID: 15262849
[TBL] [Abstract][Full Text] [Related]
17. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
18. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials.
Yap YG; Duong T; Bland M; Malik M; Torp-Pedersen C; Køber L; Connolly SJ; Marchant B; Camm J
Eur Heart J; 2005 Jul; 26(14):1385-93. PubMed ID: 15914501
[TBL] [Abstract][Full Text] [Related]
19. [Functional capacity in patients after myocardial infarction dependent on treatment strategy in acute phase of disease].
Lakusić N; Mahović D; Cerovec D; Baborski F; Majsec M
Acta Med Croatica; 2005; 59(4):341-5. PubMed ID: 16334743
[TBL] [Abstract][Full Text] [Related]
20. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling.
Solomon SD; Anavekar NS; Greaves S; Rouleau JL; Hennekens C; Pfeffer MA;
J Am Coll Cardiol; 2004 May; 43(9):1511-4. PubMed ID: 15120803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
